AKT1 and central nervous system cancer: When activated, AMPK can indirectly or directly reduce the phosphorylation level of PI3K or prevent the activation of AKT to inhibit the activity of the PI3K/AKT pathway, thereby interfering with various malignant phenotypes of glioma stem cells, including proliferation, migration, invasion, and resistance to apoptosis (93).